Niagen Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAGE and other ETFs, options, and stocks.

About NAGE

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). 

CEO
Robert N. Fried
CEORobert N. Fried
Employees
117
Employees117
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
1999
Founded1999
Employees
117
Employees117

NAGE Key Statistics

Market cap
282.74M
Market cap282.74M
Price-Earnings ratio
16.54
Price-Earnings ratio16.54
Dividend yield
Dividend yield
Average volume
1.00M
Average volume1.00M
High today
$3.71
High today$3.71
Low today
$3.50
Low today$3.50
Open price
$3.62
Open price$3.62
Volume
812.33K
Volume812.33K
52 Week high
$14.69
52 Week high$14.69
52 Week low
$3.50
52 Week low$3.50

Stock Snapshot

With a market cap of 282.74M, Niagen Bioscience(NAGE) trades at $3.50. The stock has a price-to-earnings ratio of 16.54.

On 2026-06-02, Niagen Bioscience(NAGE) stock moved within a range of $3.50 to $3.71. With shares now at $3.50, the stock is trading 0.0% above its intraday low and -5.7% below the session's peak.

Trading volume for Niagen Bioscience(NAGE) stock has reached 812.33K, versus its average volume of 1M.

Over the past 52 weeks, Niagen Bioscience(NAGE) stock has traded between a high of $14.69 and a low of $3.50.

Over the past 52 weeks, Niagen Bioscience(NAGE) stock has traded between a high of $14.69 and a low of $3.50.

NAGE News

Simply Wall St 2h
Is Niagen Bioscience’s NAD+ Research Push Quietly Redefining Its Competitive Moat?

Niagen Bioscience, Inc. recently renamed its ChromaDex External Research Program as the Niagen Research Program and introduced a Trainee Grant Program to suppor...

Is Niagen Bioscience’s NAD+ Research Push Quietly Redefining Its Competitive Moat?
TipRanks 6h
Niagen Bioscience renames CERP to Niagen Research Program

Niagen Bioscience (NAGE) announced the official renaming of the ChromaDex External Research Program, CERP, to the Niagen Research Program, reflecting the Compan...

People also own

Based on the portfolios of people who own NAGE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.